Verrica Pharmaceuticals
+$0.04 (+2.30%) Today
+$0.02 (+1.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRCA and other ETFs, options, and stocks.
About VRCA
Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris.
CEO
Ted White
Employees
38
Headquarters
West Chester, Pennsylvania
Founded
2013
VRCA Key Statistics
Market cap
55.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.29M
High today
$2.20
Low today
$1.96
Open price
$2.18
Volume
916.64K
52 Week high
$14.79
52 Week low
$1.80
Analyst ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
VRCA Earnings
-$0.52
-$0.35
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market